查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386214

全球白血病治疗市场：趋势、预测与竞争分析（~2030 年）

Leukemia Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

白血病治疗趋势和预测

预计到2030年，全球白血病治疗市场规模将达到约214.6亿美元，2024年至2030年年复合成长率为8.4%。该市场的主要驱动因素是白血病盛行率的增加、对更有效的白血病治疗的需求不断增加以及医疗保健行业的研发费用增加。全球白血病治疗市场前景广阔，医院药局、药局和零售药局以及线上供应商市场都有商机。

白血病治疗市场洞察

Lucintel 预测，由于慢性淋巴性白血病慢性淋巴性白血病的产品核可增加以及针对慢性淋巴性白血病的白血病治疗方法的存在，慢性淋巴细胞白血病在预测期内仍将是最大的细分市场。

由于大众对白血病及其治疗方案的认识不断提高，以及寻求医院治疗的人数增加，医院药局将继续成为该市场的最大细分市场。

由于白血病治疗再生医学领域的研究不断增加以及对个人化医疗的认识不断增强，预计北美在预测期内将出现最高的成长。

市场规模/估计：以金额的白血病治疗市场规模估计（10亿美元）

趋势和预测分析：各细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）

细分市场分析：按类型、药物、配销通路和地区估算的白血病治疗市场规模（金额十亿美元）

区域分析：北美、欧洲、亚太地区和世界其他地区白血病治疗市场细分

成长机会：按类型、药物、配销通路和地区分類的白血病治疗市场成长机会分析

策略分析：白血病治疗市场併购、新产品开发、竞争形势等

基于波特五力模型的产业竞争实力分析

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球白血病治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球白血病治疗市场趋势（2018-2023）与预测（2024-2030）
  • 全球白血病治疗市场：按类型
    • 急性淋巴性白血病
    • 急性骨髓性白血病
    • 慢性淋巴性白血病
    • 慢性骨髓性白血病
    • 其他的
  • 全球白血病治疗市场：依药物分类
    • 化疗
    • 标靶治疗/免疫治疗
  • 全球白血病治疗市场：按配销通路
    • 医院药房
    • 药局/零售药房
    • 线上提供者

第4章市场趋势与预测分析：按地区（2018-2030）

  • 全球白血病治疗市场：按地区
  • 北美白血病治疗市场
  • 欧洲白血病治疗市场
  • 亚太白血病治疗市场
  • 其他地区白血病治疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球白血病治疗市场成长机会
    • 全球白血病治疗市场药物成长机会
    • 按配销通路的全球白血病治疗市场成长机会
    • 全球白血病治疗市场按地区成长机会
  • 全球白血病治疗市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球白血病治疗市场的产能
    • 全球白血病治疗市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Bristol-Myers Squibb
  • Takeda Pharmaceutical
  • Lupin
  • Gilead Sciences
  • Novartis
  • Amgen
  • Teva Pharmaceutical Industries
  • Abbvie
  • Pfizer
  • Sanofi
简介目录

Leukemia Therapeutics Trends and Forecast

The future of the global leukemia therapeutics market looks promising with opportunities in the hospital pharmacies, drug store and retail pharmacies, and online provider markets. The global leukemia therapeutics market is expected to reach an estimated $21.46 billion by 2030 with a CAGR of 8.4% from 2024 to 2030. The major drivers for this market are growing incidence of leukemia, increasing need for more effective treatment for lukemia and rising R&D spending in the healthcare industry.

A more than 150-page report is developed to help in your business decisions.

Leukemia Therapeutics by Segment

The study includes a forecast for the global leukemia therapeutics by type, drug, distribution channel, and region.

Leukemia Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • Others

Leukemia Therapeutics Market by Drug [Shipment Analysis by Value from 2018 to 2030]:

  • Chemotherapy
  • Targeted Therapy and Immunotherapy

Leukemia Therapeutics Market by Distribution channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Drug Store and Retail Pharmacies
  • Online Providers

Leukemia Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Leukemia Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies leukemia therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the leukemia therapeutics companies profiled in this report include-

  • Bristol-Myers Squibb
  • Takeda Pharmaceutical
  • Lupin
  • Gilead Sciences
  • Novartis
  • Amgen
  • Teva Pharmaceutical Industries
  • Abbvie
  • Pfizer
  • Sanofi

Leukemia Therapeutics Market Insights

Lucintel forecasts that chronic lymphocytic leukemia will remain the largest segment over the forecast period due to increase in product approvals for chronic lymphocytic leukemia and presence of leukemia therapeutics for chronic lymphocytic leukemia.

Within this market, hospital pharmacies will remain the largest segment due to growing public awareness regarding leukemia and its treatment options along with increasing number of people seeking treatment in hospitals.

North America is expected to witness highest growth over the forecast period due to growing research in the field of regenerative medicine for the treatment of leukemia and rising awareness on personalized medicine in the region.

Features of the Global Leukemia Therapeutics Market

Market Size Estimates: Leukemia therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Leukemia therapeutics market size by type, drug, distribution channel, and region in terms of value ($B).

Regional Analysis: Leukemia therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, drugs, distribution channels, and regions for the leukemia therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the leukemia therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the leukemia therapeutics market size?

Answer: The global leukemia therapeutics market is expected to reach an estimated $21.46 billion by 2030.

Q.2 What is the growth forecast for leukemia therapeutics market?

Answer: The global leukemia therapeutics market is expected to grow with a CAGR of 8.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the leukemia therapeutics market?

Answer: The major drivers for this market are growing incidence of leukemia, increasing need for more effective treatment for lukemia and rising R&D spending in the healthcare industry.

Q4. What are the major segments for leukemia therapeutics market?

Answer: The future of the leukemia therapeutics market looks promising with opportunities in the hospital pharmacies, drug store and retail pharmacies, and online provider markets.

Q5. Who are the key leukemia therapeutics market companies?

Answer: Some of the key leukemia therapeutics companies are as follows:

  • Bristol-Myers Squibb
  • Takeda Pharmaceutical
  • Lupin
  • Gilead Sciences
  • Novartis
  • Amgen
  • Teva Pharmaceutical Industries
  • Abbvie
  • Pfizer
  • Sanofi

Q6. Which leukemia therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that chronic lymphocytic leukemia will remain the largest segment over the forecast period due to increase in product approvals for chronic lymphocytic leukemia and presence of leukemia therapeutics for chronic lymphocytic leukemia.

Q7. In leukemia therapeutics market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing research in the field of regenerative medicine for the treatment of leukemia and rising awareness on personalized medicine in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the leukemia therapeutics market by type (acute lymphocytic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia,chronic myeloid leukemia, and others), drug (chemotherapy, and targeted therapy & immunotherapy), distribution channel (hospital pharmacies, drug store and retail pharmacies, and online providers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Leukemia Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Leukemia Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Leukemia Therapeutics Market by Type
    • 3.3.1: Acute Lymphocytic Leukemia
    • 3.3.2: Acute Myeloid Leukemia
    • 3.3.3: Chronic Lymphocytic Leukemia
    • 3.3.4: Chronic Myeloid Leukemia
    • 3.3.5: Others
  • 3.4: Global Leukemia Therapeutics Market by Drug
    • 3.4.1: Chemotherapy
    • 3.4.2: Targeted Therapy and Immunotherapy
  • 3.5: Global Leukemia Therapeutics Market by Distribution channel
    • 3.5.1: Hospital Pharmacies
    • 3.5.2: Drug Store and Retail Pharmacies
    • 3.5.3: Online Providers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Leukemia Therapeutics Market by Region
  • 4.2: North American Leukemia Therapeutics Market
    • 4.2.2: North American Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers
  • 4.3: European Leukemia Therapeutics Market
    • 4.3.1: European Leukemia Therapeutics Market by Type: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and Others
    • 4.3.2: European Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers
  • 4.4: APAC Leukemia Therapeutics Market
    • 4.4.1: APAC Leukemia Therapeutics Market by Type: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and Others
    • 4.4.2: APAC Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers
  • 4.5: ROW Leukemia Therapeutics Market
    • 4.5.1: ROW Leukemia Therapeutics Market by Type: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, and Others
    • 4.5.2: ROW Leukemia Therapeutics Market by Distribution channel: Hospital Pharmacies, Drug Store and Retail Pharmacies, and Online Providers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Leukemia Therapeutics Market by Type
    • 6.1.2: Growth Opportunities for the Global Leukemia Therapeutics Market by Drug
    • 6.1.3: Growth Opportunities for the Global Leukemia Therapeutics Market by Distribution channel
    • 6.1.4: Growth Opportunities for the Global Leukemia Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Leukemia Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Leukemia Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Leukemia Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bristol-Myers Squibb
  • 7.2: Takeda Pharmaceutical
  • 7.3: Lupin
  • 7.4: Gilead Sciences
  • 7.5: Novartis
  • 7.6: Amgen
  • 7.7: Teva Pharmaceutical Industries
  • 7.8: Abbvie
  • 7.9: Pfizer
  • 7.10: Sanofi